These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 29450744)
1. High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation. Jin F; Hagemann N; Sun L; Wu J; Doeppner TR; Dai Y; Hermann DM Angiogenesis; 2018 May; 21(2):381-394. PubMed ID: 29450744 [TBL] [Abstract][Full Text] [Related]
2. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371 [TBL] [Abstract][Full Text] [Related]
3. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Ruiz M; Okada H; Dahlbäck B Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022 [TBL] [Abstract][Full Text] [Related]
4. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway. Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703 [TBL] [Abstract][Full Text] [Related]
5. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. González-Díez M; Rodríguez C; Badimon L; Martínez-González J Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. Wilkerson BA; Grass GD; Wing SB; Argraves WS; Argraves KM J Biol Chem; 2012 Dec; 287(53):44645-53. PubMed ID: 23135269 [TBL] [Abstract][Full Text] [Related]
7. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Galvani S; Sanson M; Blaho VA; Swendeman SL; Obinata H; Conger H; Dahlbäck B; Kono M; Proia RL; Smith JD; Hla T Sci Signal; 2015 Aug; 8(389):ra79. PubMed ID: 26268607 [TBL] [Abstract][Full Text] [Related]
8. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189 [TBL] [Abstract][Full Text] [Related]
10. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437 [TBL] [Abstract][Full Text] [Related]
11. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252 [TBL] [Abstract][Full Text] [Related]
12. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis. Zhu GS; Tang LY; Lv DL; Jiang M Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966 [TBL] [Abstract][Full Text] [Related]
14. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway. Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828 [TBL] [Abstract][Full Text] [Related]
15. LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network trafficking. Jin F; Hagemann N; Brockmeier U; Schäfer ST; Zechariah A; Hermann DM Angiogenesis; 2013 Jul; 16(3):625-37. PubMed ID: 23429999 [TBL] [Abstract][Full Text] [Related]
16. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3. Tölle M; Klöckl L; Wiedon A; Zidek W; van der Giet M; Schuchardt M Biochem Biophys Res Commun; 2016 Aug; 476(4):627-634. PubMed ID: 27282481 [TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION. Asghar MY; Magnusson M; Kemppainen K; Sukumaran P; Löf C; Pulli I; Kalhori V; Törnquist K J Biol Chem; 2015 Jun; 290(26):16116-31. PubMed ID: 25971967 [TBL] [Abstract][Full Text] [Related]
18. VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia. Cannizzo CM; Adonopulos AA; Solly EL; Ridiandries A; Vanags LZ; Mulangala J; Yuen SCG; Tsatralis T; Henriquez R; Robertson S; Nicholls SJ; Di Bartolo BA; Ng MKC; Lam YT; Bursill CA; Tan JTM FASEB J; 2018 Jun; 32(6):2911-2922. PubMed ID: 29401597 [TBL] [Abstract][Full Text] [Related]